Acute worsening of glycemic control in a patient with type 2 diabetes and non‐small cell lung cancer after administration of lorlatinib

por Nakano, Yoshio, Miyasato‐Isoda, Mai, Gohma, Iwao, Fujisawa, Tomomi
Publicado 2022

Intrapericardial carboplatin in the management of malignant pericardial effusion in breast cancer: a pilot study

por Kotake, Mie, Imai, Hisao, Kaira, Kyoichi, Fujisawa, Tomomi, Yanagita, Yasuhiro, Minato, Koichi
Publicado 2019

Genetic dissection of susceptibility genes for diabetes and related phenotypes on mouse chromosome 14 by means of congenic strains

por Babaya, Naru, Ueda, Hironori, Noso, Shinsuke, Hiromine, Yoshihisa, Itoi-Babaya, Michiko, Kobayashi, Misato, Fujisawa, Tomomi, Ikegami, Hiroshi
Publicado 2014

Verification That Mouse Chromosome 14 Is Responsible for Susceptibility to Streptozotocin in NSY Mice

por Babaya, Naru, Ueda, Hironori, Noso, Shinsuke, Hiromine, Yoshihisa, Itoi-Babaya, Michiko, Kobayashi, Misato, Fujisawa, Tomomi, Ikegami, Hiroshi
Publicado 2018

Type 2 diabetes susceptibility genes on mouse chromosome 11 under high sucrose environment

por Kobayashi, Misato, Ueda, Hironori, Babaya, Naru, Itoi-Babaya, Michiko, Noso, Shinsuke, Fujisawa, Tomomi, Horio, Fumihiko, Ikegami, Hiroshi
Publicado 2020

Promoter Polymorphism of RGS2 Gene Is Associated with Change of Blood Pressure in Subjects with Antihypertensive Treatment: The Azelnidipine and Temocapril in Hypertensive Patients...

por Sugimoto, Ken, Katsuya, Tomohiro, Kamide, Kei, Fujisawa, Tomomi, Shimaoka, Izumi, Ohishi, Mitsuru, Morishita, Ryuichi, Ogihara, Toshio, Rakugi, Hiromi
Publicado 2010

Dose Effect and Mode of Inheritance of Diabetogenic Gene on Mouse Chromosome 11

por Babaya, Naru, Ueda, Hironori, Noso, Shinsuke, Hiromine, Yoshihisa, Nojima, Koji, Itoi-Babaya, Michiko, Kobayashi, Misato, Fujisawa, Tomomi, Ikegami, Hiroshi
Publicado 2013

Novel loci for hyperglycemia identified by QTL mapping of longitudinal phenotypes and congenic analysis

por Babaya, Naru, Itoi-Babaya, Michiko, Ueda, Hironori, Kobayashi, Misato, Noso, Shinsuke, Hiromine, Yoshihisa, Ishikawa, Akira, Fujisawa, Tomomi, Ikegami, Hiroshi
Publicado 2023

Extracapsular Invasion of Sentinel Lymph Nodes Is Not Associated With Disease Recurrence in Breast Cancer

por Fujii, Takaaki, Yajima, Reina, Yamaguchi, Satoru, Yanagita, Yasuhiro, Fujisawa, Tomomi, Hirakata, Tomoko, Tsutsumi, Soichi, Asao, Takayuki, Iijima, Misa, Kuwano, Hiroyuki
Publicado 2014

Insulin Transactivator MafA Regulates Intrathymic Expression of Insulin and Affects Susceptibility to Type 1 Diabetes

por Noso, Shinsuke, Kataoka, Kohsuke, Kawabata, Yumiko, Babaya, Naru, Hiromine, Yoshihisa, Yamaji, Kaori, Fujisawa, Tomomi, Aramata, Shinsaku, Kudo, Takashi, Takahashi, Satoru, Ikegami, Hiroshi
Publicado 2010

Pharmacogenomic–pharmacokinetic study of selective estrogen-receptor modulators with intra-patient dose escalation in breast cancer

por Ishiguro, Hiroshi, Ohno, Shinji, Yamamoto, Yutaka, Takao, Shintaro, Sato, Nobuaki, Fujisawa, Tomomi, Kadoya, Takayuki, Kuroi, Katsumasa, Bando, Hiroko, Teramura, Yasufumi, Iwata, Hiroji, Tanaka, Shiro, Toi, Masakazu
Publicado 2019

Health-related quality of life and estimation of the minimally important difference in the Functional Assessment of Cancer Therapy-Endocrine Symptom score in postmenopausal ER+/HER...

por Kikawa, Yuichiro, Hagiwara, Yasuhiro, Fujisawa, Tomomi, Araki, Kazuhiro, Iwamoto, Takayuki, Sangai, Takafumi, Shien, Tadahiko, Takao, Shintaro, Nishimura, Reiki, Takahashi, Masato, Toyama, Tatsuya, Aihara, Tomohiko, Mukai, Hirofumi, Taira, Naruto
Publicado 2022

Distinct gene expression profiles between primary breast cancers and brain metastases from pair-matched samples

por Iwamoto, Takayuki, Niikura, Naoki, Ogiya, Rin, Yasojima, Hiroyuki, Watanabe, Ken-ichi, Kanbayashi, Chizuko, Tsuneizumi, Michiko, Matsui, Akira, Fujisawa, Tomomi, Iwasa, Tsutomu, Shien, Tadahiko, Saji, Shigehira, Masuda, Norikazu, Iwata, Hiroji
Publicado 2019

Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy

por Iwata, Hiroji, Yamamoto, Yutaka, Sakai, Takehiko, Hasegawa, Yoshie, Nakamura, Rikiya, Akabane, Hiromitsu, Ohtani, Shoichiro, Kashiwaba, Masahiro, Taira, Naruto, Toyama, Tatsuya, Fujisawa, Tomomi, Masuda, Norikazu, Shibahara, Yukiko, Sasano, Hironobu, Yamaguchi, Takuhiro
Publicado 2023

Serum lipid and bone metabolism effects of Toremifene vs. Letrozole as adjuvant therapy for postmenopausal early breast cancer patients: results of a multicenter open randomized st...

por Shien, Tadahiko, Doihara, Hiroyoshi, Sato, Nobuaki, Anan, Keisei, Komaki, Kansei, Miyauchi, Keisuke, Yanagita, Yasuhiro, Fujisawa, Tomomi, Mitsuyama, Shoshu, Kanbayashi, Chizuko, Kusama, Mikihiro, Kimura, Morihiko, Jinno, Hiromitsu, Sano, Muneaki, Ikeda, Tadashi
Publicado 2017

Patients Offer Radiofrequency Ablation Therapy for Early Breast Cancer as Local Therapy (PO-RAFAELO) Study under the Patient-proposed Health Services

por Takayama, Shin, Kinoshita, Takayuki, Shiino, Sho, Jimbo, Kenjiro, Watanabe, Ken-ichi, Fujisawa, Tomomi, Yamamoto, Naohito, Onishi, Tatsuya, Shien, Tadahiko, Ito, Mitsuya, Takahashi, Mina, Futamura, Manabu, Aruga, Tomoyuki, Kaneko, Koji, Suto, Akihiko
Publicado 2023

Comparison of immune microenvironments between primary tumors and brain metastases in patients with breast cancer

por Ogiya, Rin, Niikura, Naoki, Kumaki, Nobue, Yasojima, Hiroyuki, Iwasa, Tsutomu, Kanbayashi, Chizuko, Oshitanai, Risa, Tsuneizumi, Michiko, Watanabe, Ken-ichi, Matsui, Akira, Fujisawa, Tomomi, Saji, Shigehira, Masuda, Norikazu, Tokuda, Yutaka, Iwata, Hiroji
Publicado 2017

Confirmation of Multiple Risk Loci and Genetic Impacts by a Genome-Wide Association Study of Type 2 Diabetes in the Japanese Population

por Takeuchi, Fumihiko, Serizawa, Masakuni, Yamamoto, Ken, Fujisawa, Tomomi, Nakashima, Eitaro, Ohnaka, Keizo, Ikegami, Hiroshi, Sugiyama, Takao, Katsuya, Tomohiro, Miyagishi, Makoto, Nakashima, Naoki, Nawata, Hajime, Nakamura, Jiro, Kono, Suminori, Takayanagi, Ryoichi, Kato, Norihiro
Publicado 2009

Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)

por Aogi, Kenjiro, Watanabe, Kenichi, Kitada, Masahiro, Sangai, Takafumi, Ohtani, Shoichiro, Aruga, Tomoyuki, Kawaguchi, Hidetoshi, Fujisawa, Tomomi, Maeda, Shigeto, Morimoto, Takashi, Sato, Nobuaki, Takao, Shintaro, Morita, Satoshi, Masuda, Norikazu, Toi, Masakazu, Ohno, Shinji
Publicado 2021

Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)

por Aogi, Kenjiro, Watanabe, Kenichi, Kitada, Masahiro, Sangai, Takafumi, Ohtani, Shoichiro, Aruga, Tomoyuki, Kawagichi, Hidetoshi, Fujisawa, Tomomi, Maeda, Shigeto, Morimoto, Takashi, Sato, Nobuaki, Takao, Shintaro, Morita, Satoshi, Masuda, Norikazu, Toi, Masakazu, Ohno, Shinji
Publicado 2021